| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/20/2005 | US20050013859 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 01/20/2005 | US20050013858 Sustained release formulation; shorter treatment duration; higher tolerance; fungal infections |
| 01/20/2005 | US20050013857 Highly plastic granules for making fast melting tablets |
| 01/20/2005 | US20050013856 Solid dispersions comprising a hygroscopic and/or deliquescent drug |
| 01/20/2005 | US20050013855 siRNA associated with lipid precipitate; in vivo delivery to cytosol |
| 01/20/2005 | US20050013854 Novel encochleation methods, cochleates and methods of use |
| 01/20/2005 | US20050013852 Rapid release, water permeable self adhesive polymer matrix system; photodynamic therapy and/or diagnosis of skin lesions |
| 01/20/2005 | US20050013845 Adhesive bioerodible ocular drug delivery system |
| 01/20/2005 | US20050013840 Penetrating skin with water soluble, lipid soluble and/or biodegradable pioneer projectile followed by therapeutic agent; needleless injection |
| 01/20/2005 | US20050013835 Stable non-dihydrate azithromycin oral suspensions |
| 01/20/2005 | US20050013834 Pharmaceutical formulations comprising ketoconazole |
| 01/20/2005 | US20050013833 Composition based on lipid lamellar vesicles incorporating at least a dhea compound |
| 01/20/2005 | US20050013831 Obtained from neisseria meningitidis and commensal neisseria; broad spectrum protective immunity |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | US20050013812 Infectious diseases, allergies, cancer; kits |
| 01/20/2005 | US20050013810 Regulating immune response using dendritic cells |
| 01/20/2005 | US20050013792 Dispersion containing ion exchange matrix drug complex; shelf life |
| 01/20/2005 | US20050013780 Hollow microspheres with controlled fragility for medical use |
| 01/20/2005 | US20050012115 Ion sensitive field effect transistor and method for producing an ion sensitive field effect transistor |
| 01/20/2005 | DE20221087U1 Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen Transdermal therapeutic system with fentanyl and related substances |
| 01/20/2005 | DE10343746B3 Production of vitamin E succinate compactate, useful for making pressed molding, especially tablets, uses relatively low temperature for compacting in press agglomerator, milling and classification |
| 01/20/2005 | DE10339864A1 Coffein enthaltende Tablette Caffeine-containing tablet |
| 01/20/2005 | DE10330243A1 Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis Use of products derived from extremophilic bacteria osmolytes for the production of drugs for external treatment of atopic dermatitis |
| 01/20/2005 | DE10330026A1 Using sweetener acid for stabilization of foods, cosmetics, consumer goods and pharmaceuticals, provides low pH with less perceived acidity, compared with usual food acids |
| 01/20/2005 | CA2532337A1 Stable pharmaceutical formulation |
| 01/20/2005 | CA2531640A1 Intravaginal drug delivery devices |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2531419A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 01/20/2005 | CA2531396A1 Dispenser with reservoir containing a drug of abuse |
| 01/20/2005 | CA2531116A1 Diffusion layer modulated solids |
| 01/20/2005 | CA2531025A1 Process for the preparation of micron-size crystalline particles using a solvent, a non-solvent and ultrasonic energy |
| 01/20/2005 | CA2530531A1 Formulations for coated microprojections containing non-volatile counterions |
| 01/20/2005 | CA2530529A1 Compositions and methods for selective dissolution of nascent intravascular blood clots |
| 01/20/2005 | CA2529606A1 Pharmaceutical composition for solubility enhancement of hydrophobic drugs |
| 01/20/2005 | CA2529598A1 Stable freeze-dried pharmaceutical formulation of tetrodotoxin |
| 01/20/2005 | CA2529461A1 Novel solid pharmaceutical composition comprising amisulpride |
| 01/20/2005 | CA2528465A1 Compositions and methods for enhanced mucosal delivery of growth hormone |
| 01/19/2005 | EP1498420A1 Phospholipid derivative |
| 01/19/2005 | EP1498395A1 Use of a glass composition with the aim of attaining an antioxidative effect |
| 01/19/2005 | EP1498150A1 Delivery of solid drug compositions |
| 01/19/2005 | EP1498143A1 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 01/19/2005 | EP1498142A1 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 01/19/2005 | EP1498141A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/19/2005 | EP1498135A1 Dental viscous pharmaceutical containing basic fibroblast growth factor |
| 01/19/2005 | EP1498130A1 Pharmaceutical composition of 4 herb extracts and method for its manufacture |
| 01/19/2005 | EP1498120A1 Semi-solid formulations for the oral administration of taxoids |
| 01/19/2005 | EP1498119A1 Use of conjugated linoleic acid for treating colds |
| 01/19/2005 | EP1498118A1 Patch and process for producing the same |
| 01/19/2005 | EP1498117A1 A pharmaceutical gelatin-capsule or gelatin containing capsule preparation showing an improved stability, a process for making the capsules and a process for improving the stability of gelatin-capsules |
| 01/19/2005 | EP1498116A1 Method of manufacturing chemical-containing composite particles |
| 01/19/2005 | EP1498115A1 Preparation of particles for inhalation |
| 01/19/2005 | EP1498114A1 Soft tablet containing high molecular weight cellulosics |
| 01/19/2005 | EP1497442A2 Biologic modulations with nanoparticles |
| 01/19/2005 | EP1497345A2 New film coating |
| 01/19/2005 | EP1497323A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein |
| 01/19/2005 | EP1497289A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496967A1 Therapeutic dry powder preparation |
| 01/19/2005 | EP1496955A1 Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques |
| 01/19/2005 | EP1496951A1 Wound dressings comprising hydrated hydrogels and enzymes |
| 01/19/2005 | EP1496942A1 Microparticles comprising carbohydrate beads covalently linked with allergen |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496902A1 Medicaments containing steroids and a novel anticholinesterase drug |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496885A1 Use of conjugated linoleic acid derivatives |
| 01/19/2005 | EP1496882A1 Tolterodine salts |
| 01/19/2005 | EP1496876A2 Aerosol formulation for inhalation comprising a tiotropium salt |
| 01/19/2005 | EP1496875A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 01/19/2005 | EP1496874A1 Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496872A2 Functional foods containing a phospholipid-containing stable matrix |
| 01/19/2005 | EP1496871A1 Polysaccharide capsules and methods of preparation |
| 01/19/2005 | EP1496870A1 Dosage form and method for producing the same |
| 01/19/2005 | EP1496869A1 Coated particles with prolonged release and tablets containing same |
| 01/19/2005 | EP1496868A1 Controlled release pharmaceutical compositions of carbidopa and levodopa |
| 01/19/2005 | EP1496867A1 Drug-complex microparticles and methods of making/using same |
| 01/19/2005 | EP1496866A2 Process for preparing tannate liquid and semi-solid dosage forms |
| 01/19/2005 | EP1496865A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 01/19/2005 | EP1496864A2 Pharmaceutical composition containing lamotrigine particles of defined morphology |
| 01/19/2005 | EP1496862A1 Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 01/19/2005 | EP1496861A2 Method of inhibiting restenosis |
| 01/19/2005 | EP1496860A1 Localized non-invasive biological modulation system |
| 01/19/2005 | EP1496859A1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 01/19/2005 | EP1496858A1 Inhalation kit comprisung inhalable powder of tiotropium |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496840A1 Moisture triggered release systems comprising aroma ingredients providing fragrance burst in response to moisture |
| 01/19/2005 | EP1496835A2 Compositions and methods for systemic inhibition of cartilage degradation |
| 01/19/2005 | EP1496823A2 Antimicrobial surfaces |
| 01/19/2005 | EP1438087A4 System for administering a drug delivery device |
| 01/19/2005 | EP1423019A4 Process for preparing concentrate thickener compositions |
| 01/19/2005 | EP1395268B1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 01/19/2005 | EP1395241B1 Implantable medical device with controllable gaseous agent release system |
| 01/19/2005 | EP1355633B1 NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
| 01/19/2005 | EP1341498A4 Medicated tattoos |
| 01/19/2005 | EP1318721A4 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 01/19/2005 | EP1265615B1 Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis |
| 01/19/2005 | EP1227792B1 Ocular insert |
| 01/19/2005 | EP1216091B9 Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent |
| 01/19/2005 | EP1198494B1 Preparations that are devoid of cross-linking agents |